Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
Grasser
B
B
Karl-Franzens-University of Graz, Department of Surgery, Division of Transplantation, Auenbruggerplatz, Graz, Austria.
Iberer
F
F
Schaffellner
S
S
Kniepeiss
D
D
Stauber
R
R
Koshsorur
G
G
Rehak
P
P
Tscheliessnigg
K H
KH
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000097:blood* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D011183:Postoperative Complications; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009173:Mycophenolic Acid; D001663:Bilirubin